James C. Blair, Director, 10% Owner at CADENCE PHARMACEUTICALS INC (CADX), sold 149 shares at $5.00 ($746) on 2013-02-13, disclosed to the SEC on 2013-02-15.
Scheduled sale ($746) by Director, 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.00 | 98 | $490 | 65.7% |
| 2 | $5.01 | 51 | $256 | 34.3% |
| Total | $5.00 avg | 149 | $746 | 100% |
| Filing → |
| BNGO | BUY | 2018-08-27 | $92K | — | Filing → |
| CLVS | SELL | 2017-08-08 | $2.9M | — | Filing → |
| EVOK | SELL | 2016-05-27 | $1.6M | — | Filing → |